Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer

被引:153
作者
Jiang, Guanglong [1 ,2 ]
Zhang, Shijun [1 ,2 ]
Yazdanparast, Aida [1 ,2 ]
Li, Meng [1 ,2 ]
Pawar, Aniruddha Vikram [1 ,2 ]
Liu, Yunlong [1 ,2 ]
Inavolu, Sai Mounika [1 ,2 ]
Cheng, Lijun [1 ,2 ]
机构
[1] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
来源
BMC GENOMICS | 2016年 / 17卷
关键词
Heterogeneous; Breast cancer; DNA mutation; mRNA expression; Copy number alteration; Reverse-phase protein array; Molecular portraits; Cell lines; GENOME-WIDE ASSOCIATION; MUTATIONAL EVOLUTION; PROTEIN ABUNDANCE; GENE-EXPRESSION; MODELS; SUBTYPES; SIGNATURES; LANDSCAPE; DISCOVERY; RESOURCE;
D O I
10.1186/s12864-016-2911-z
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Proper cell models for breast cancer primary tumors have long been the focal point in the cancer's research. The genomic comparison between cell lines and tumors can investigate the similarity and dissimilarity and help to select right cell model to mimic tumor tissues to properly evaluate the drug reaction in vitro. In this paper, a comprehensive comparison in copy number variation (CNV), mutation, mRNA expression and protein expression between 68 breast cancer cell lines and 1375 primary breast tumors is conducted and presented. Results: Using whole genome expression arrays, strong correlations were observed between cells and tumors. PAM50 gene expression differentiated them into four major breast cancer subtypes: Luminal A and B, HER2amp, and Basal-like in both cells and tumors partially. Genomic CNVs patterns were observed between tumors and cells across chromosomes in general. High C > T and C > G trans-version rates were observed in both cells and tumors, while the cells had slightly higher somatic mutation rates than tumors. Clustering analysis on protein expression data can reasonably recover the breast cancer subtypes in cell lines and tumors. Although the drug-targeted proteins ER/PR and interesting mTOR/GSK3/TS2/PDK1/ER_P118 cluster had shown the consistent patterns between cells and tumor, low protein-based correlations were observed between cells and tumors. The expression consistency of mRNA verse protein between cell line and tumors reaches 0.7076. These important drug targets in breast cancer, ESR1, PGR, HER2, EGFR and AR have a high similarity in mRNA and protein variation in both tumors and cell lines. GATA3 and RP56KB1 are two promising drug targets for breast cancer. A total score developed from the four correlations among four molecular profiles suggests that cell lines, BT483, T47D and MDAMB453 have the highest similarity with tumors. Conclusions: The integrated data from across these multiple platforms demonstrates the existence of the similarity and dissimilarity of molecular features between breast cancer tumors and cell lines. The cell lines only mirror some but not all of the molecular properties of primary tumors. The study results add more evidence in selecting cell line models for breast cancer research.
引用
收藏
页数:21
相关论文
共 44 条
  • [1] [Anonymous], 2011, R LANG ENV STAT COMP
  • [2] The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    Barretina, Jordi
    Caponigro, Giordano
    Stransky, Nicolas
    Venkatesan, Kavitha
    Margolin, Adam A.
    Kim, Sungjoon
    Wilson, Christopher J.
    Lehar, Joseph
    Kryukov, Gregory V.
    Sonkin, Dmitriy
    Reddy, Anupama
    Liu, Manway
    Murray, Lauren
    Berger, Michael F.
    Monahan, John E.
    Morais, Paula
    Meltzer, Jodi
    Korejwa, Adam
    Jane-Valbuena, Judit
    Mapa, Felipa A.
    Thibault, Joseph
    Bric-Furlong, Eva
    Raman, Pichai
    Shipway, Aaron
    Engels, Ingo H.
    Cheng, Jill
    Yu, Guoying K.
    Yu, Jianjun
    Aspesi, Peter, Jr.
    de Silva, Melanie
    Jagtap, Kalpana
    Jones, Michael D.
    Wang, Li
    Hatton, Charles
    Palescandolo, Emanuele
    Gupta, Supriya
    Mahan, Scott
    Sougnez, Carrie
    Onofrio, Robert C.
    Liefeld, Ted
    MacConaill, Laura
    Winckler, Wendy
    Reich, Michael
    Li, Nanxin
    Mesirov, Jill P.
    Gabriel, Stacey B.
    Getz, Gad
    Ardlie, Kristin
    Chan, Vivien
    Myer, Vic E.
    [J]. NATURE, 2012, 483 (7391) : 603 - 607
  • [3] International Variation in Prostate Cancer Incidence and Mortality Rates
    Center, Melissa M.
    Jemal, Ahmedin
    Lortet-Tieulent, Joannie
    Ward, Elizabeth
    Ferlay, Jacques
    Brawley, Otis
    Bray, Freddie
    [J]. EUROPEAN UROLOGY, 2012, 61 (06) : 1079 - 1092
  • [4] The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
    Curtis, Christina
    Shah, Sohrab P.
    Chin, Suet-Feung
    Turashvili, Gulisa
    Rueda, Oscar M.
    Dunning, Mark J.
    Speed, Doug
    Lynch, Andy G.
    Samarajiwa, Shamith
    Yuan, Yinyin
    Graef, Stefan
    Ha, Gavin
    Haffari, Gholamreza
    Bashashati, Ali
    Russell, Roslin
    McKinney, Steven
    Langerod, Anita
    Green, Andrew
    Provenzano, Elena
    Wishart, Gordon
    Pinder, Sarah
    Watson, Peter
    Markowetz, Florian
    Murphy, Leigh
    Ellis, Ian
    Purushotham, Arnie
    Borresen-Dale, Anne-Lise
    Brenton, James D.
    Tavare, Simon
    Caldas, Carlos
    Aparicio, Samuel
    [J]. NATURE, 2012, 486 (7403) : 346 - 352
  • [5] Modeling precision treatment of breast cancer
    Daemen, Anneleen
    Griffith, Obi L.
    Heiser, Laura M.
    Wang, Nicholas J.
    Enache, Oana M.
    Sanborn, Zachary
    Pepin, Francois
    Durinck, Steffen
    Korkola, James E.
    Griffith, Malachi
    Hur, Joe S.
    Huh, Nam
    Chung, Jongsuk
    Cope, Leslie
    Fackler, Mary Jo
    Umbricht, Christopher
    Sukumar, Saraswati
    Seth, Pankaj
    Sukhatme, Vikas P.
    Jakkula, Lakshmi R.
    Lu, Yiling
    Mills, Gordon B.
    Cho, Raymond J.
    Collisson, Eric A.
    van't Veer, Laura J.
    Spellman, Paul T.
    Gray, Joe W.
    [J]. GENOME BIOLOGY, 2013, 14 (10):
  • [6] Evaluating cell lines as tumour models by comparison of genomic profiles
    Domcke, Silvia
    Sinha, Rileen
    Levine, Douglas A.
    Sander, Chris
    Schultz, Nikolaus
    [J]. NATURE COMMUNICATIONS, 2013, 4
  • [7] Genome-wide association study identifies novel breast cancer susceptibility loci
    Easton, Douglas F.
    Pooley, Karen A.
    Dunning, Alison M.
    Pharoah, Paul D. P.
    Thompson, Deborah
    Ballinger, Dennis G.
    Struewing, Jeffery P.
    Morrison, Jonathan
    Field, Helen
    Luben, Robert
    Wareham, Nicholas
    Ahmed, Shahana
    Healey, Catherine S.
    Bowman, Richard
    Meyer, Kerstin B.
    Haiman, Christopher A.
    Kolonel, Laurence K.
    Henderson, Brian E.
    Le Marchand, Loic
    Brennan, Paul
    Sangrajrang, Suleeporn
    Gaborieau, Valerie
    Odefrey, Fabrice
    Shen, Chen-Yang
    Wu, Pei-Ei
    Wang, Hui-Chun
    Eccles, Diana
    Evans, D. Gareth
    Peto, Julian
    Fletcher, Olivia
    Johnson, Nichola
    Seal, Sheila
    Stratton, Michael R.
    Rahman, Nazneen
    Chenevix-Trench, Georgia
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Axelsson, Christen K.
    Garcia-Closas, Montserrat
    Brinton, Louise
    Chanock, Stephen
    Lissowska, Jolanta
    Peplonska, Beata
    Nevanlinna, Heli
    Fagerholm, Rainer
    Eerola, Hannaleena
    Kang, Daehee
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Sei-Hyun
    [J]. NATURE, 2007, 447 (7148) : 1087 - U7
  • [8] Breast cancer genome-wide association studies: there is strength in numbers
    Fanale, D.
    Amodeo, V.
    Corsini, L. R.
    Rizzo, S.
    Bazan, V.
    Russo, A.
    [J]. ONCOGENE, 2012, 31 (17) : 2121 - 2128
  • [9] COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
    Forbes, Simon A.
    Tang, Gurpreet
    Bindal, Nidhi
    Bamford, Sally
    Dawson, Elisabeth
    Cole, Charlotte
    Kok, Chai Yin
    Jia, Mingming
    Ewing, Rebecca
    Menzies, Andrew
    Teague, Jon W.
    Stratton, Michael R.
    Futreal, P. Andrew
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 : D652 - D657
  • [10] Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO